Literature DB >> 7556739

Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis.

J G Dowler1, P G Hykin, S L Lightman, A M Hamilton.   

Abstract

Although pre-operative retinopathy severity appears to be a major factor in determining the visual outcome of diabetic extracapsular cataract extraction, its precise relationship to post-operative visual acuity is ill defined. A meta-analysis was therefore carried out, and studies were included if pre-operative maculopathy and retinopathy status was sufficiently defined to permit discrimination of visual outcome between subgroups. Weighted mean proportions of eyes achieving a post-operative visual acuity > or = 6/12 were as follows: no retinopathy, 87%; non-proliferative retinopathy with no maculopathy, 80%; quiescent proliferative retinopathy with no maculopathy, 57%; non-proliferative retinopathy with maculopathy, 41%; quiescent proliferative retinopathy with maculopathy, 11%; active proliferative retinopathy, 0. Differences in visual outcome between groups were significant (chi 2 = 119.9, p < 0.0005), attributable mostly to the trend across groups (chi 2 for trend = 115.4, p < 0.0005). Logistic regression indicated that maculopathy was a more potent predictor of post-operative visual acuity < or = 6/12 (odds ratio 6.4, 95% CI 4.13-9.94, p < 0.0005) than quiescent proliferative retinopathy (odds ratio 3.33, 95% CI 2.04-5.42, p < 0.0005). The severity of retinopathy and maculopathy prior to cataract surgery in diabetics are the major determinants of post-operative visual acuity. Further study of the relationship between pre-operative retinopathy severity and the incidence of post-operative complications, progression of retinopathy and maculopathy is required to optimise the management of cataract in diabetes.

Entities:  

Mesh:

Year:  1995        PMID: 7556739     DOI: 10.1038/eye.1995.61

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus.

Authors:  J L Borrillo; R A Mittra; S Dev; W F Mieler; S Pescinski; A Prasad; P K Rao; S B Koenig
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

3.  Identification and Description of Reliable Evidence for 2016 American Academy of Ophthalmology Preferred Practice Pattern Guidelines for Cataract in the Adult Eye.

Authors:  Asieh Golozar; Yujiang Chen; Kristina Lindsley; Benjamin Rouse; David C Musch; Flora Lum; Barbara S Hawkins; Tianjing Li
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

4.  Visual outcome after phacoemulsification and IOL implantation in diabetic patients.

Authors:  A Zaczek; G Olivestedt; C Zetterström
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

5.  A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes.

Authors:  D Squirrell; R Bhola; J Bush; S Winder; J F Talbot
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

6.  Cataract surgical outcomes in diabetic patients: case control study.

Authors:  Oluwatoyin H Onakpoya; Charles O Bekibele; Stella A Adegbehingbe
Journal:  Middle East Afr J Ophthalmol       Date:  2009-04

7.  The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.

Authors:  Maged S Habib; Paul S Cannon; David H W Steel
Journal:  BMC Ophthalmol       Date:  2005-06-22       Impact factor: 2.209

8.  Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants.

Authors:  Y Yang; C Bailey; F G Holz; N Eter; M Weber; C Baker; S Kiss; U Menchini; J M Ruiz Moreno; P Dugel; A Lotery
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

9.  Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.

Authors:  Zhale Rajavi; Sare Safi; Mohammad Ali Javadi; Mohsen Azarmina; Siamak Moradian; Morteza Entezari; Ramin Nourinia; Hamid Ahmadieh; Armin Shirvani; Saeid Shahraz; Alireza Ramezani; Mohammad Hossein Dehghan; Mohsen Shahsavari; Masoud Soheilian; Homayoun Nikkhah; Hossein Ziaei; Hasan Behboudi; Fereydoun Farrahi; Khalil Ghasemi Falavarjani; Mohammad Mehdi Parvaresh; Hamid Fesharaki; Majid Abrishami; Nasser Shoeibi; Mansour Rahimi; Alireza Javadzadeh; Reza Karkhaneh; Mohammad Riazi-Esfahani; Masoud Reza Manaviat; Alireza Maleki; Bahareh Kheiri; Faegheh Golbafian
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

Review 10.  Ocular Complications of Diabetes and Therapeutic Approaches.

Authors:  Victoria J Vieira-Potter; Dimitrios Karamichos; Darren J Lee
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.